One-Shot gene therapy trial offers hope for devastating childhood disorder
NCT ID NCT07480564
Summary
This study is testing a single injection of an experimental gene therapy called TSHA-102 in three young girls with Rett syndrome. The goal is to see if the treatment is safe and if it can help control the disease by targeting its genetic cause. Participants will be followed closely for five years after receiving the injection.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETT SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.